Garland Eric L, Bryan Craig J, Nakamura Yoshio, Froeliger Brett, Howard Matthew O
University of Utah, 395 South, 1500 East, Salt Lake City, UT, 84112, USA.
Medical University of South Carolina, Charleston, CS, USA.
Psychopharmacology (Berl). 2017 Feb;234(4):621-629. doi: 10.1007/s00213-016-4494-4. Epub 2016 Dec 8.
Prescription opioid misuse and high-dose opioid use may result in allostatic dysregulation of hedonic brain circuitry, leading to reduced emotion regulation capacity. In particular, opioid misuse may blunt the ability to experience and upregulate positive affect from natural rewards.
The purpose of this study was to examine associations between opioid use/misuse and autonomic indices of emotion regulation capability in a sample of chronic pain patients receiving prescription opioid pharmacotherapy.
Chronic pain patients taking long-term opioid analgesics (N = 40) completed an emotion regulation task while heart rate variability (HRV) was recorded, and also completed self-report measures of opioid misuse, craving, pain severity, and emotional distress. Based on a validated cut-point on the Current Opioid Misuse Measure, participants were grouped as opioid misusers or non-misusers. Opioid misuse status and morphine equivalent daily dose (MEDD) were examined as predictors of HRV and self-reports of emotion regulation.
Opioid misusers exhibited significantly less HRV during positive and negative emotion regulation, and significantly less positive effect, than non-misusers, after controlling for confounders including pain severity and emotional distress. MEDD was inversely associated with positive emotion regulation efficacy.
Findings implicate the presence of reward processing deficits among chronic pain patients with opioid-misusing behaviors, and opioid dosage was associated with deficient emotion regulation, suggesting the presence of compromised top-down cognitive control over bottom-up hedonic processes. Emotion regulation among opioid misusers may represent an important treatment target.
处方阿片类药物滥用和高剂量阿片类药物使用可能导致享乐性脑回路的稳态失调,从而降低情绪调节能力。特别是,阿片类药物滥用可能会削弱从自然奖励中体验和上调积极情绪的能力。
本研究的目的是在接受处方阿片类药物药物治疗的慢性疼痛患者样本中,研究阿片类药物使用/滥用与情绪调节能力的自主指标之间的关联。
服用长期阿片类镇痛药的慢性疼痛患者(N = 40)在记录心率变异性(HRV)的同时完成一项情绪调节任务,并完成阿片类药物滥用、渴望、疼痛严重程度和情绪困扰的自我报告测量。根据当前阿片类药物滥用测量的有效切点,将参与者分为阿片类药物滥用者或非滥用者。将阿片类药物滥用状态和吗啡等效日剂量(MEDD)作为HRV和情绪调节自我报告的预测因素进行研究。
在控制了包括疼痛严重程度和情绪困扰在内的混杂因素后,阿片类药物滥用者在积极和消极情绪调节期间的HRV明显低于非滥用者,积极情绪也明显较少。MEDD与积极情绪调节效果呈负相关。
研究结果表明,有阿片类药物滥用行为的慢性疼痛患者存在奖励处理缺陷,阿片类药物剂量与情绪调节不足有关,这表明自上而下的认知控制对自下而上的享乐过程存在受损。阿片类药物滥用者的情绪调节可能是一个重要的治疗靶点。